Drawing for MEDICSBLU

USPTO serial 79300680

MEDICSBLU

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
HUDSON, TAMARA BREE
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MEDICSBLU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Light therapy devices for medical purposes; radiotherapy apparatus; electromedical instruments; apparatus and installations comprising illuminants such as LED lamps for use in light therapy for medical purposes; light and radiotherapy apparatus in pacifier form; light and radiotherapy apparatus in the form of rods; sex toys; sex aids; aids for sexual stimulation for adults; sexual activity apparatus, devices and articles; artificial penises, being adult sexual aidsACTIVE
011Light therapy devices for cosmetic purposes; apparatus and installations comprising illuminants such as LED lamps for use in light therapy for cosmetic purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 22, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB
Nov 20, 2022FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Nov 3, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Nov 2, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 12, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 25, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 2, 2021MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 2, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 11, 2021RFNTREFUSAL PROCESSED BY IB
Apr 21, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 21, 2021RFRRREFUSAL PROCESSED BY MPU
Apr 10, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 9, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2021DOCKASSIGNED TO EXAMINER
Jan 1, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Dec 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance